Not for release, publication or distribution, in whole or in part, directly or indirectly, into Australia, Canada, the Hong Kong Special Administrative Region of the People’s Republic of China, Japan or the United States (or any other jurisdiction in which release, publication or distribution would be unlawful). This announcement does not constitute an offer of the securities described herein.

Reference is made to the stock exchange announcement of SoftOx Solutions AS (the “Company”) regarding the rights issue of up to 1,237,508,259 new shares in the Company.

The rights trading period for the Rights Issue ends today, Monday, August 19, at 16:30 (CEST). Subscription rights to participate in the Rights Issue can be exercised during the ongoing subscription period, which ends on Friday, August 23, at 16:30 (CEST).

Subscription rights that are not used to subscribe for new shares by the end of the subscription period on Friday, August 23 at 4:30 p.m. (CEST) or that are not sold by Monday, August 19 at 4:30 p.m. (CEST) will lose their value and expire without compensation to the holder.

For further information, please see the rights issue prospectus dated 5 August 2024.

If you have any questions, please contact: Geir Almås, Chairman of SoftOx Solutions AS Mail: [email protected] Phone: Geir Almås: (+47) 977 59 071 About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx) is a medical technology and pharmaceutical company listed on Euronext Growth Oslo under “SOFTX”. SoftOx Solutions AS was founded in 2012 and is headquartered in Oslo. The SoftOx Solutions Group includes the holding company SoftOx Solutions AS, the Malmö-based subsidiary Water Innovation AB and the subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx develops a highly effective antimicrobial solution for biofilms, viral and antibiotic-resistant infections. The patent-protected technology is based on extensive research and development in collaboration with leading Nordic research institutes.

For more information about SoftOx, visit www.soft-ox.com

IMPORTANT NOTICES This announcement does not constitute, and does not form part of, an offer to sell or the solicitation of an offer to buy any securities of the Company. The distribution of this announcement and other information may be restricted by law in certain jurisdictions. Copies of this announcement will not be made and may not be distributed or sent into any jurisdiction in which such distribution would be unlawful or would require registration or other action. Persons into whose possession this announcement or other information comes are required to inform themselves about and observe any such restrictions. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company is doing so.

https://newsweb.oslobors.no/message/625496